Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Status:
Completed
Trial end date:
2018-01-09
Target enrollment:
Participant gender:
Summary
This randomized clinical trial studies metformin hydrochloride in overweight or obese
patients at elevated risk for breast cancer. Metformin hydrochloride may decrease the
expression of early tumor makers in breast tissue of patients at increased risk for breast
cancer